This product demonstrates simultaneous, high-efficiency efficacy against the adults, nymphs, and eggs of both red spider mite and two-spotted spider mites. Mortality among adults and nymphs occurs continuously over a period of 12 to 72 hours; the onset of mortality is faster at higher temperatures and slower at lower temperatures, with the ultimate mortality rate consistently exceeding 90%. Peak mortality is reached within 1 to 3 days, followed by egg hatching between days 4 and 7; mortality continues for a total of 10 days, and the residual efficacy period lasts for 20 to 40 days.
This product inhibits the protein activity in mite eggs, preventing normal hatching and causing egg masses to discolor and deform. It also alters the activity of protein enzymes in mites, paralyzing the central nervous system of both adult mites and nymphs. As a result, they are unable to metabolize, move, or feed. Their cuticle and body cells rapidly shrink and dehydrate, ultimately leading to death and disintegration.